Nextage Therapeutics Ltd (NXTG.TA)

ILA 72.8

(-3.45%)

Annual Income Statements

(In ILS)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 876 Thousand - 91 Thousand 191 Thousand 297 Thousand 383 Thousand
Cost of Revenue 651 Thousand - 75 Thousand 154 Thousand 90 Thousand 87 Thousand
Gross Profit 225 Thousand - 16 Thousand 37 Thousand 207 Thousand 296 Thousand
Operating Expenses 4.21 Million 5.84 Million 6.46 Million 5.15 Million 2.05 Million 9.63 Million
Selling, General and Administrative Expenses 1.41 Million 1.95 Million 1.35 Million 833 Thousand 1.95 Million 2.3 Million
Research and Development Expenses 976 Thousand 1.84 Million 2.06 Million 808 Thousand 1.1 Million 6.28 Million
Other Expenses 1.82 Million 19 Thousand - - - -
Cost and Expenses 4.86 Million 5.84 Million 6.54 Million 5.31 Million 2.14 Million 9.72 Million
Operating Income -3.98 Million -5.84 Million -7.67 Million -15.78 Million -4.4 Million -10.05 Million
Interest Expense 50 Thousand 25 Thousand 159 Thousand 106 Thousand 241 Thousand -
Income Tax Expense - -115 Thousand 925 Thousand 2.68 Million 2.55 Million 1.28 Million
Earnings before Tax -4.2 Million -5.98 Million -7.93 Million -15.96 Million -2.08 Million -8.74 Million
Net Income -3.87 Million -5.98 Million -7.72 Million -15.96 Million -2.08 Million -8.73 Million
Earnings Per Share Basic -0.13 - -0.30 -1.40 -1.15 -6.88
Earnings Per Share Diluted -0.13 - -0.30 -1.40 -1.15 -6.88
Weighted Average Shares Outstanding 29.18 Million - 26.03 Million 11.42 Million 1.81 Million 1.26 Million
Weighted Average Shares Outstanding (Diluted) 29.18 Million - 26.03 Million 11.42 Million 1.81 Million 1.26 Million
Gross Margin 0.26 - 0.18 0.19 0.70 0.77
EBIT Margin -4.59 - -69.87 -67.51 -5.67 -11.28
Profit Margin -4.43 - -84.92 -83.59 -7.03 -22.81
EBITDA -4.02 Million -5.9 Million -7.58 Million -15.87 Million -4.4 Million -4.32 Million
Earnings Before Tax Margin -4.55 - -84.37 -82.62 -14.83 -26.24

Income Statement Charts